By Chris Hutching
Friday 22nd November 2002 |
Text too small? |
Brokers said investors keen on the stock had already bought shares in recent months when the price reached a high of 20c. Listed Southern Capital, another in Mr Paterson's stable, owns 4.3% of the 166,666,666 shares on issue bought at 10c a share.
Botry-Zen manufactures a biological control against fruit fungus Botrytis cinerea, which often affects grapevines. The company forecasts sales of $1.2 million next year and a $135,000 profit in the year to March 31, 2004, but expects a $926,000 shortfall this year as it sets up operations.
Botry-Zen was initially floated last year to private investors in a $5 million capital raising. In July it was granted registration for grape application under the Pesticides Act.
No comments yet
October 3rd Morning Report
BRW - Bremworth Enters Into Scheme Implementation Agreement
October 2nd Morning Report
Devon Funds Morning Note - 2 October 2025
Meridian welcomes Government reforms
October 1st Morning Report
Heartland publishes Annual Report, Climate Report and NOM
SCL - Scales increases ownership of Australian Joint Ventures
Cooks Coffee Company Trading Update
September 30th Morning Report